Results 131 to 140 of about 18,744,545 (170)

Synaptic density changes following electroconvulsive therapy: A longitudinal pilot study with PET-MR 11C-UCB-J imaging in late-life depression

open access: yesBrain Stimulation
Maarten Laroy   +11 more
doaj   +3 more sources

In Vivo Synaptic Density Imaging with 11C-UCB-J Detects Treatment Effects of Saracatinib in a Mouse Model of Alzheimer Disease. [PDF]

open access: yesJ Nucl Med, 2019
Toyonaga T   +11 more
europepmc   +1 more source

A new phenylstannyl precursor for synthesizing [11C]UCB-J

open access: yesA new phenylstannyl precursor for synthesizing [11C]UCB-J
openaire   +1 more source

Building an open infrastructure for molecular neuroimaging: Standards and tools from the OpenNeuroPET initiative. [PDF]

open access: yesJ Cereb Blood Flow Metab
Ganz M   +19 more
europepmc   +1 more source

Effects of radiotherapy on synaptic density as assessed by [11C]UCB-J PET in the brains of patients with head and neck cancer

open access: yes
van der Weijden, Chris W.J.   +7 more
openaire   +1 more source

Preclinical PET Studies of [11C]UCB-J Binding in Minipig Brain

Molecular Imaging and Biology, 2020
Purpose: Loss of neuronal synapse function is associated with a number of brain disorders. The [11C]UCB-J positron emission tomography (PET) tracer allows for in vivo examination of synaptic density, as it binds to synaptic vesicle glycoprotein 2A (SV2A) expressed in presynaptic terminals.
Betina Elfving   +2 more
exaly   +4 more sources

Principal component analysis of synaptic density measured with [11C]UCB-J PET in Alzheimer's disease

The American Journal of Geriatric Psychiatry, 2021
Introduction Synaptic loss has been cited as an early pathological event and major structural correlate of cognitive impairment in Alzheimer's disease (AD). However, this observation is based on limited neuropathological studies. Here, we examined the in vivo relationship between synaptic density and cognitive performance in early AD using [11C]UCB-J ...
Ryan O'Dell   +17 more
openaire   +1 more source

Home - About - Disclaimer - Privacy